Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
01/07/2024 | 22:05 | GlobeNewswire Inc. | AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary | NASDAQ:AMRS | Amyris Inc |
23/04/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMRS | Amyris Inc |
02/04/2024 | 12:06 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:AMRS | Amyris Inc |
05/01/2024 | 22:22 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:AMRS | Amyris Inc |
18/08/2023 | 01:35 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:AMRS | Amyris Inc |
14/08/2023 | 13:15 | IH Market News | Monday’s Wall Street Highlights: US Steel, Tesla, Nikola, AMC Entertainment, and more | NASDAQ:AMRS | Amyris Inc |
12/08/2023 | 04:32 | KR Market News | 소매 투자자들이 페니 주식에 집중: 위워크, 아미리스 | NASDAQ:AMRS | Amyris Inc |
10/08/2023 | 14:34 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:AMRS | Amyris Inc |
10/08/2023 | 13:12 | IH Market News | Thursday’s Wall Street Highlights: Capri Holdings, Disney, Sonos, Applovin, Plug Power, and more | NASDAQ:AMRS | Amyris Inc |
10/08/2023 | 05:20 | KR Market News | 생명공학 회사 아미리스, 미국에서 파산 신청 | NASDAQ:AMRS | Amyris Inc |
10/08/2023 | 03:38 | PR Newswire (US) | AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION | NASDAQ:AMRS | Amyris Inc |
29/06/2023 | 22:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AMRS | Amyris Inc |
26/06/2023 | 15:10 | PR Newswire (US) | AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE | NASDAQ:AMRS | Amyris Inc |
09/06/2023 | 22:15 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AMRS | Amyris Inc |
05/06/2023 | 14:37 | PR Newswire (US) | AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING | NASDAQ:AMRS | Amyris Inc |
19/05/2023 | 14:00 | PR Newswire (US) | AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE | NASDAQ:AMRS | Amyris Inc |
09/05/2023 | 22:05 | PR Newswire (US) | AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS | NASDAQ:AMRS | Amyris Inc |
02/05/2023 | 14:00 | PR Newswire (US) | AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9 | NASDAQ:AMRS | Amyris Inc |
25/04/2023 | 12:06 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AMRS | Amyris Inc |
24/04/2023 | 14:59 | PR Newswire (US) | AMYRIS REPORTS Q1 2023 REVENUE | NASDAQ:AMRS | Amyris Inc |
22/04/2023 | 00:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMRS | Amyris Inc |
11/04/2023 | 22:37 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:AMRS | Amyris Inc |
11/04/2023 | 22:35 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:AMRS | Amyris Inc |
07/04/2023 | 00:35 | Edgar (US Regulatory) | Amended Report of Proposed Sale of Securities (144/a) | NASDAQ:AMRS | Amyris Inc |
05/04/2023 | 14:00 | PR Newswire (US) | AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN | NASDAQ:AMRS | Amyris Inc |
31/03/2023 | 22:35 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:AMRS | Amyris Inc |
17/03/2023 | 11:01 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AMRS | Amyris Inc |
15/03/2023 | 21:21 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) | NASDAQ:AMRS | Amyris Inc |
15/03/2023 | 21:11 | PR Newswire (US) | AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS | NASDAQ:AMRS | Amyris Inc |
28/02/2023 | 14:00 | PR Newswire (US) | AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023 | NASDAQ:AMRS | Amyris Inc |